News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
193 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Make Sure Moisture Analysis Is Accurate With New White Paper From METTLER TOLEDO
October’s e-calendar offer from METTLER TOLEDO will help users learn to ensure reliable halogen moisture analyzer results through an easy, 10-minute routine test.
October 30, 2017
·
1 min read
Policy
INSYS Therapeutics to Record a Minimum Liability for Department of Justice Settlement in Q3 2017
As of Sept. 30, 2017, $150 million has been accrued, which represents our best estimate of the minimum liability exposure we expect to pay over five years.
October 30, 2017
·
3 min read
Policy
INSYS Therapeutics Affirms Its Commitment to Sustainable Future Growth
The company’s CEO has released a statement regarding the events of the past few days.
October 30, 2017
·
2 min read
Business
INSYS Therapeutics Announces Resignation of Patrick P. Fourteau From Board of Directors
Mr. Fourteau cited personal reasons for stepping down from the board.
October 30, 2017
·
2 min read
Drug Development
CARMAT Accelerates the Internationalization of the PIVOTAL Study and Obtains the Approval to Perform Implants in the Czech Republic
CARMAT announces it has received the approval to perform, within the framework of the PIVOTAL study protocol approved by the ANSM (French national agency for the safety of medicines and health products),
October 30, 2017
·
3 min read
Pluristem Proposes to Launch a Public Offering of Common Stock on the Tel Aviv Stock Exchange After Concluding an Israeli Institutional Investors Tender
The Company has engaged Leader Underwriters (1993) Ltd. (“Leader”) as its advisor for the offering.
October 30, 2017
·
5 min read
Okayama University Research: Link Between Biological-Clock Disturbance and Brain Dysfunction Found
Researchers at Okayama University describe in the Journal of Neuroscience that a certain protein known to play a major role in circadian rhythmicity --humans’ intrinsic 24-hour biological cycle -- is also key to proper brain functioning.
October 30, 2017
·
4 min read
Business
Igenomix US and PracticeHwy.com Announce a New Collaboration
This collaboration will allow unprecedented access and ease of ordering/receiving test results to the more than 130 IVF centers who currently use eIVF in their practice.
October 30, 2017
·
3 min read
Crescendo Bioscience Announces Six Presentations at the American College of Rheumatology 2017 Annual Meeting
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. , today announced that six studies on Vectra® DA will be featured at the American College of Rheumatology (ACR) meeting being held Nov. 3-8, 2017 in San Diego,
October 30, 2017
·
4 min read
Business
Astellas Appoints Gary Thal, M.D., to VP, Specialty, Medical Affairs, Americas
Astellas today announced Gary Thal, M.D., has been promoted to VP, Specialty, Medical Affairs, Americas and will assume overall responsibility for the strategic direction of the Specialty product portfolio.
October 30, 2017
·
2 min read
Previous
15 of 20
Next